These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29053124)

  • 1. [The efficacy of cerebrolysin in the treatment of autism spectrum disorders].
    Chutko LS; Yakovenko EA; Surushkina SY; Kryukova EM; Palaieva SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):71-75. PubMed ID: 29053124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An effect of long-term cerebrolysin therapy in combination with neuroleptics on behavioral and cognitive disturbances in endogenous childhood autism].
    Radzivil MG; Bashina VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(2):21-5. PubMed ID: 16548370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical improvement following vitamin D3 supplementation in Autism Spectrum Disorder.
    Feng J; Shan L; Du L; Wang B; Li H; Wang W; Wang T; Dong H; Yue X; Xu Z; Staal WG; Jia F
    Nutr Neurosci; 2017 Jun; 20(5):284-290. PubMed ID: 26783092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences Between the Childhood Autism Rating Scale and the Social Responsiveness Scale in Assessing Symptoms of Children with Autistic Spectrum Disorder.
    Chen KL; Lin CH; Yu TY; Huang CY; Chen YD
    J Autism Dev Disord; 2018 Sep; 48(9):3191-3198. PubMed ID: 29696524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A follow-up study on the long-term effects of rehabilitation in children with autism spectrum disorders.
    Zhang L; Liu Y; Zhou Z; Wei Y; Wang J; Yang J; Wu Y; Sun Y
    NeuroRehabilitation; 2019; 44(1):1-7. PubMed ID: 30714977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vitamin A supplementation on gut microbiota in children with autism spectrum disorders - a pilot study.
    Liu J; Liu X; Xiong XQ; Yang T; Cui T; Hou NL; Lai X; Liu S; Guo M; Liang XH; Cheng Q; Chen J; Li TY
    BMC Microbiol; 2017 Sep; 17(1):204. PubMed ID: 28938872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descriptive characteristics of children with autism at Autism Treatment Center, KSA.
    Al Shirian S; Al Dera H
    Physiol Behav; 2015 Nov; 151():604-8. PubMed ID: 26343774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pathophysiological analysis of cerebrolysin therapy of children with mental developmental delay caused by ecological factors].
    Govorin NV; Zlova TP; Akhmetova VV; Tarasova OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(5):51-5. PubMed ID: 18577958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders.
    Lemonnier E; Villeneuve N; Sonie S; Serret S; Rosier A; Roue M; Brosset P; Viellard M; Bernoux D; Rondeau S; Thummler S; Ravel D; Ben-Ari Y
    Transl Psychiatry; 2017 Mar; 7(3):e1056. PubMed ID: 28291262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children.
    Saad K; Abdel-Rahman AA; Elserogy YM; Al-Atram AA; Cannell JJ; Bjørklund G; Abdel-Reheim MK; Othman HA; El-Houfey AA; Abd El-Aziz NH; Abd El-Baseer KA; Ahmed AE; Ali AM
    Nutr Neurosci; 2016 Oct; 19(8):346-351. PubMed ID: 25876214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [S100B protein in the blood of children with autism spectrum disorders].
    Golubova TF; Tsukurova L; Korsunskaya LL; Osipyan RR; Vlasenko SV; Savchuk EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12):76-83. PubMed ID: 31994518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of cerebrolysin on cognitive functions in childhood autism and in Asperger syndrome].
    Krasnoperova MG; Bashina VM; Skvortsov IA; Simashkova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(6):15-8. PubMed ID: 12872620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Placebo-Controlled Crossover Trial of Gastrin-Releasing Peptide in Childhood Autism.
    Marchezan J; Becker M; Schwartsmann G; Ohlweiler L; Roesler R; Renck LB; Gonçalves MMM; Ranzan J; Riesgo RDS
    Clin Neuropharmacol; 2017; 40(3):108-112. PubMed ID: 28452904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling clinical outcome of children with autistic spectrum disorders.
    Coplan J; Jawad AF
    Pediatrics; 2005 Jul; 116(1):117-22. PubMed ID: 15995041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of autism spectrum disorder symptoms in three children by using gastrin-releasing peptide.
    Becker MM; Bosa C; Oliveira-Freitas VL; Goldim JR; Ohlweiler L; Roesler R; Schwartsmann G; Riesgo Rdos S
    J Pediatr (Rio J); 2016; 92(3):302-6. PubMed ID: 26893210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of cerebrolysin in the treatment of prolonged extrapyramidal complications of neuroleptic therapy].
    Kontsevoĭ VA; Medvedev AV; Andrusenko MP; Zvenigorodskaia IuV; Sheshenin VS
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(6):39-44. PubMed ID: 11517474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and electroencephalographic characteristics of specific language impairment in children and an evaluation of the efficacy of cerebrolysin].
    Chutko LS; Surushkina SY; Yakovenko EA; Sergeev AV; Rozhkova AV; Anosova LV; Chistyakova NP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):98-102. PubMed ID: 26356521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Learning and Memory Calcineurin Binding Protein with Autism Spectrum Disorders.
    Alhowikan AM; ayadhi LY; Alkhedaide AQ
    J Coll Physicians Surg Pak; 2017 Feb; 27(2):84-87. PubMed ID: 28292384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrolysin therapy in Rett syndrome: clinical and EEG mapping study.
    Gorbachevskaya N; Bashina V; Gratchev V; Iznak A
    Brain Dev; 2001 Dec; 23 Suppl 1():S90-3. PubMed ID: 11738849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Atomoxetine in Individuals with Attention-Deficit/Hyperactivity Disorder and Low-Functioning Autism Spectrum Disorder.
    Kilincaslan A; Mutluer TD; Pasabeyoglu B; Tutkunkardas MD; Mukaddes NM
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):798-806. PubMed ID: 27228116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.